Sanara MedTech, Inc. (SMTI)
35.13
+0.06
(+0.17%)
USD |
NASDAQ |
Oct 12, 10:56
Sanara MedTech Enterprise Value : 355.51M for Oct. 9, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 355.51M |
| October 08, 2026 | 355.33M |
| October 07, 2026 | 355.33M |
| October 06, 2026 | 354.87M |
| October 05, 2026 | 354.87M |
| October 02, 2026 | 353.49M |
| October 01, 2026 | 353.77M |
| September 30, 2026 | 356.16M |
| September 29, 2026 | 355.70M |
| September 28, 2026 | 355.79M |
| September 25, 2026 | 355.42M |
| September 24, 2026 | 355.79M |
| September 23, 2026 | 356.25M |
| September 22, 2026 | 357.44M |
| September 21, 2026 | 356.43M |
| September 18, 2026 | 355.51M |
| September 17, 2026 | 354.68M |
| September 16, 2026 | 355.79M |
| September 15, 2026 | 355.88M |
| September 14, 2026 | 354.68M |
| September 11, 2026 | 354.13M |
| September 10, 2026 | 355.14M |
| September 09, 2026 | 355.14M |
| September 08, 2026 | 355.33M |
| September 04, 2026 | 352.39M |
| Date | Value |
|---|---|
| September 03, 2026 | 352.29M |
| September 02, 2026 | 353.03M |
| September 01, 2026 | 352.94M |
| August 31, 2026 | 353.77M |
| August 28, 2026 | 350.92M |
| August 27, 2026 | 351.01M |
| August 26, 2026 | 351.65M |
| August 25, 2026 | 351.83M |
| August 24, 2026 | 349.17M |
| August 21, 2026 | 349.81M |
| August 20, 2026 | 347.88M |
| August 19, 2026 | 348.25M |
| August 18, 2026 | 347.24M |
| August 17, 2026 | 345.68M |
| August 14, 2026 | 347.05M |
| August 13, 2026 | 347.15M |
| August 12, 2026 | 348.71M |
| August 11, 2026 | 349.17M |
| August 10, 2026 | 347.97M |
| August 07, 2026 | 346.59M |
| August 06, 2026 | 346.50M |
| August 05, 2026 | 346.32M |
| August 04, 2026 | 346.23M |
| August 03, 2026 | 345.68M |
| July 31, 2026 | 344.39M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Intelligent Bio Solutions, Inc. | 2.052M |
| Anteris Technologies Global Corp. | 405.69M |
| 20/20 Biolabs, Inc. | 2.159M |
| Quest Diagnostics, Inc. | 31.55B |
| Labcorp Holdings, Inc. | 31.89B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.4111M |
| Revenue (Quarterly) | 28.14M |
| Total Expenses (Quarterly) | 28.55M |
| EPS Diluted (Quarterly) | -0.0523 |
| Gross Profit Margin (Quarterly) | 90.76% |
| Profit Margin (Quarterly) | -1.46% |
| Earnings Yield | -10.56% |
| Operating Earnings Yield | 3.73% |
| Normalized Earnings Yield | -9.862 |